Skip to main
KPTI
KPTI logo

Karyopharm Therapeutics (KPTI) Earnings Dates & Reports

Karyopharm Therapeutics (KPTI) Most Recent Earnings

Report DateAug 11, 2025
Period EndingQ2 2025
Est. EPS-$3.86
Actual EPS-$4.32
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Karyopharm Therapeutics (KPTI) Earnings per Share (EPS) History

Signup for full access
Browse free

Karyopharm Therapeutics (KPTI) Latest Earnings

The value each KPTI share was expected to gain vs. the value each share gained.

Karyopharm Therapeutics (KPTI) reported its most recent earnings on Aug 11, 2025 for Q2 2025, posting earnings per share (EPS) of -$4.32. This exceeded analysts' expectations of -$3.86 by 11.92%, marking a Miss.

For comparison, Karyopharm Therapeutics reported EPS of -$3 in the same quarter last year.

The company is expected to announce its next earnings report on 11/04/2025, with analysts projecting an EPS of -$3.05.

Karyopharm Therapeutics (KPTI) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2025Nov 4, 2025
-$3.05Next earnings call Nov. 4, 2025
Q2 2025Aug 11, 2025
-$3.86-$4.32+11.92%
Q1 2025May 12, 2025
-$3.09-$2.77-10.36%
Q4 2024Feb 19, 2025
-$4.05-$3.60-11.11%
Q3 2024Nov 5, 2024
-$3.90-$3.900.00%
View all

Karyopharm Therapeutics (KPTI) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Karyopharm Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Aug 11, 2025
May 12, 2025
Feb 19, 2025
Nov 5, 2024

Karyopharm Therapeutics (KPTI) Earnings FAQs

Karyopharm Therapeutics (KPTI) last reported earnings on Aug 11, 2025 for Q2 2025, posting an EPS of -$4.32, which Miss the estimate of -$3.86 by 11.92%.

For Q2 2025, Karyopharm Therapeutics (KPTI) reported an EPS of -$4.32, missing analysts' estimate of -$3.86 by 11.92%.

For Q2 2025, Karyopharm Therapeutics (KPTI) Miss expectations with an actual EPS of -$4.32 vs. an estimated EPS of -$3.86.

Following the last earnings report on Aug 11, 2025, Karyopharm Therapeutics (KPTI)'s stock price moved — from — to —.

The next Karyopharm Therapeutics (KPTI) earnings call is scheduled for Nov. 4, 2025, where executives will discuss financial results and outlook.

Karyopharm Therapeutics (KPTI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.